Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis
CRISPR/Cas technology originated from the immune mechanism of archaea and bacteria and was awarded the Nobel Prize in Chemistry in 2020 for its success in gene editing. Molecular diagnostics is highly valued globally for its development as a new generation of diagnostic technology. An increasing num...
Main Authors: | Kun Chen, Ziyi Shen, Guanzhen Wang, Wei Gu, Shengchao Zhao, Zihan Lin, Wei Liu, Yi Cai, Gohar Mushtaq, Jia Jia, Chunpeng (Craig) Wan, Tingdong Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.986233/full |
Similar Items
-
Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection
by: Pooja Bhardwaj, et al.
Published: (2022-05-01) -
Recent Advances, Opportunities, and Challenges in Developing Nucleic Acid Integrated Wearable Biosensors for Expanding the Capabilities of Wearable Technologies in Health Monitoring
by: Mohammad Janghorban, et al.
Published: (2022-11-01) -
Chemically modified guide RNAs to expand CRISPR functionality
by: Taemaitree, L
Published: (2018) -
Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection
by: Zhaohe Huang, et al.
Published: (2022-09-01) -
Recent advances and challenges of the use of the CRISPR/Cas system as a non-nucleic acid molecular diagnostic
by: Jian Zhou, et al.
Published: (2023-12-01)